CSS
KALA icon

Cubist Systematic Strategies’s KALA BIO KALA Stock Holding History

Cubist Systematic Strategies’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13
Closed -$85K – 3543
2021
Q3 		$85K Sell
13
-5
-28% -$43.2K ﹤0.01% 2770
2021
Q2 		$234K Sell
18
-33
-65% -$519K ﹤0.01% 2462
2021
Q1 		$851K Sell
51
-11
-18% -$215K 0.01% 1638
2020
Q4 		$1.06M Buy
+62
New +$1.17M 0.01% 1347
2020
Q3 		– Sell
-1
Closed -$31K – 2558
2020
Q2 		$31K Buy
+1
New +$28.3K ﹤0.01% 2297
2019
Q1 		– Sell
-4
Closed -$54K – 2325
2018
Q4 		$54K Buy
+4
New +$69.3K ﹤0.01% 1859
2017
Q4 		– Sell
-4
Closed -$228K – 2001
2017
Q3 		$228K Buy
+4
New +$219K 0.01% 1360

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cubist Systematic Strategies's KALA Position: Q4 2021 in Review

Cubist Systematic Strategies sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 13 shares — an estimated $85K sold.

Cubist Systematic Strategies first reported a position in KALA in Q3 2017 and held it in 7 quarters. The position peaked at $1.06M in Q4 2020. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

  • Cubist Systematic Strategies reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 13 KALA BIO shares in Q4 2021, an estimated $85K.
  • Cubist Systematic Strategies first reported a position in KALA BIO in Q3 2017 and held it in 7 quarters.
  • Cubist Systematic Strategies's KALA BIO position peaked at $1.06M in Q4 2020.
  • 79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.